Skip to main content Accessibility help
×
Home

Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates

  • Mohammad AlGhounaim (a1), Yves Longtin (a2), Milagros Gonzales (a3), Joanna Merckx (a1) (a4), Nicholas Winters (a3) and Caroline Quach (a1) (a3) (a4)...

Abstract

BACKGROUND

Polymerase chain reaction (PCR) assays based on the detection of the toxin B gene are replacing enzyme-linked immunosorbent assay (ELISA)–based toxin production detection or cell cytotoxicity assay in most laboratories.

OBJECTIVE

To determine the proportion of pediatric patients diagnosed with Clostridium difficile infection by PCR who would have also been diagnosed by ELISA and to compare the clinical characteristics of PCR+/ELISA+ vs PCR+/ELISA− patients.

METHODS

Using the microbiology laboratory information system, stool samples positive for C. difficile by PCR between October 2010 and July 2014 were identified. Using frozen stool specimens, an ELISA for toxin A and B was performed. A retrospective medical chart review was conducted to obtain demographic and clinical data. Duplicate samples were excluded.

RESULTS

A total of 136 PCR-positive samples underwent ELISA testing: 54 (40%) were positive for toxin A or B. The mean (SD) age of the entire cohort was 8.5 (6.2) years. There was no difference in age, gender, clinical manifestation, previous medical problems, and management between patients positive or negative by ELISA. However, patients positive by ELISA were more likely to have had a recent exposure to antibiotics (67.9% vs 50%; crude odds ratio, 2.1 [95% CI, 1.03–4.28]).

CONCLUSION

In our pediatric population, 60% of patients with C. difficile diagnosed by PCR had no toxin detectable by ELISA. ELISA-negative patients were less likely to have received an antibiotic recently compared with ELISA-positive patients. These results highlight the need to standardize laboratory criteria for the diagnosis of C. difficile infections in children.

Infect Control Hosp Epidemiol 2016;37:1087–1093

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clostridium difficile Infections in Children: Impact of the Diagnostic Method on Infection Rates
      Available formats
      ×

Copyright

Corresponding author

Address correspondence to Caroline Quach, MD, MSc, McGill University Health Center, 1001 Decarie Blvd, Ste EE05-1954, Montreal (QC) H4A 3J1, Canada (caroline.quach@mcgill.ca).

Footnotes

Hide All

Presented in part: Canadian Association for Clinical Microbiology and Infectious Diseases–Association of Medical Microbiology and Infectious Disease Canada 2015 conference; April 16-18, 2015; Charlottetown, PE, Canada; abstract #SP15.

Footnotes

References

Hide All
1. Bartlett, JG. Antibiotic-associated pseudomembranous colitis. Rev Infect Dis 1979;1:530539.
2. Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 2003;41:531534.
3. O'Donoghue, C, Kyne, L. Update on Clostridium difficile infection. Curr Opin Gastroenterol 2011;27:3847.
4. Guilbault, C, Labbe, AC, Poirier, L, Busque, L, Beliveau, C, Laverdiere, M. Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens. J Clin Microbiol 2002;40:22882290.
5. Hatheway, CL. Toxigenic Clostridia. Clin Microbiol Rev 1990;3:6698.
6. Taur, Y, Pamer, EG. Harnessing microbiota to kill a pathogen: fixing the microbiota to treat Clostridium difficile infections. Nat Med 2014;20:246247.
7. Dubberke, ER, Olsen, MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012;55:S88S92.
8. Dubberke, ER, Reske, KA, Olsen, MA, McDonald, LC, Fraser, VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008;46:497504.
9. Delmee, M, Van Broeck, J, Simon, A, Janssens, M, Avesani, V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 2005;54:187191.
10. van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol 2005;43:53385340.
11. van den Berg, RJ, Bakker, D, Kuijper, EJ. Diagnosis of Clostridium difficile infection using real-time PCR. Methods Mol Biol 2013;943:247256.
12. Peterson, LR, Manson, RU, Paule, SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007;45:11521160.
13. van den Berg, RJ, Vaessen, N, Endtz, HP, Schulin, T, van der Vorm, ER, Kuijper, EJ. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol 2007;56:3642.
14. Samra, Z, Luzon, A, Bishara, J. Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins. Dig Dis Sci 2008;53:18761879.
15. Dupont, HL. Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol 2013;11:12161223.
16. Morinville, V, McDonald, J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005;19:497501.
17. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.
18. Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459477.
19. Patel, H, Randhawa, J, Nanavati, S, Marton, LR, Baddoura, WJ, DeBari, VA. Laboratory and clinical features of EIA toxin-positive and EIA toxin-negative community-acquired Clostridium difficile infection. Ann Clin Lab Sci 2015;45:333339.
20. Gonzales, M, Quach, C, Perpete, C, Moore, D. Infection Control Service Annual Report (2012-2013). Montreal: Montreal Children's Hospital; 2013.
21. Quach, C, Perpete, C, Lacharite, S. Infection Control Service Annual Report (2010-2011). Montreal: Montreal Children's Hospital; 2011.
22. Luna, RA, Boyanton, BL Jr, Mehta, S, et al. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol 2011;49:851857.
23. Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013;56:6773.
24. Khanna, S, Baddour, LM, Huskins, WC, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013;56:14011406.
25. Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015:110.
26. Snell, H, Ramos, M, Longo, S, John, M, Hussain, Z. Performance of the Techlab C. Diff Chek-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile Panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2004;42:48634865.
27. Eastwood, K, Else, P, Charlett, A, Wilcox, M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009;47:32113217.
28. Planche, TD, Davies, KA, Coen, PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 2013;13:936945.
29. Shim, JK, Johnson, S, Samore, MH, Bliss, DZ, Gerding, DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998;351:633636.
30. Kyne, L, Warny, M, Qamar, A, Kelly, CP. Asymptomatic carriage of Clostridium difficile and serum levels of IGG antibody against toxin A. N Engl J Med 2000;342:390397.
31. Rousseau, C, Poilane, I, De Pontual, L, Maherault, AC, Le Monnier, A, Collignon, A. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 2012;55:12091215.
32. Matsuki, S, Ozaki, E, Shozu, M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol 2005;8:4348.
33. Denno, DM, Shaikh, N, Stapp, JR, et al. Diarrhea etiology in a pediatric emergency department: a case control study. Clin Infect Dis 2012;55:897904.
34. Lyerly, D. The toxins of Clostridium difficile and their detection in the clinical laboratory. Clin Microbiol Updates 1992;4:16.
35. Freeman, J, Wilcox, MH. The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol 2003;56:126128.
36. Arrow, SA, Croese, L, Bowman, RA, Riley, TV. Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins. J Clin Pathol 1994;47:954956.
37. Sharp, SE, Ruden, LO, Pohl, JC, Hatcher, PA, Jayne, LM, Ivie, WM. Evaluation of the C. Diff Quik Chek Complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 2010;48:20822086.
38. Vaishnavi, C, Bhasin, D, Kochhar, R, Singh, K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect 2000;2:18271830.
39. El Feghaly, RE, Stauber, JL, Tarr, PI, Haslam, DB. Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr 2013;163:16971704.e2.
40. Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med 2015:12.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed